Equimaging
ActiveSummary
Equimaging has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €385,781 and a net result of €45,460. Equity is growing by about 24% per year across the filed financial years. Its solvency ranks better than 18% of 1,592 sector peers (NACE 75, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
- Equity
- €385,781
- Profit
- €45,460
Why 92raises riskLiquidity: current ratio 0.07, cash €17,609lowers riskSize: total assets €2.3mSector: Veterinary activities (NACE 75)Figures for financial year 2025 (filed 01-06-2026)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 75, small): better than 23% on solvency, 11% on liquidity, 51% on profitability and 64% on growth.
The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 7 accounts on average 35 days before the deadline; the sector median (NACE 75) for financial year 2024 is 6 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · micro…
- Annual accounts filedfinancial year 2024 · micro…
- Annual accounts filedfinancial year 2023 · micro…
Financials · financial year 2025, micro format
2021 to 2025, 5 financial years 2019 to 2025, 7 financial years
The operating result recovers in 2025; 2025 is 26% above 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 75, Veterinary activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Peer companies
Historical observationOf the 2,372 companies that looked in July 2024 the way this one looks now, 1.9% went bankrupt within 24 months and 96.6% are still going.
- Small
- 5 to 10 years old
- solvency 10 to 30%
- a profit under 5% of the balance sheet
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 2,372 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €2,347 | €92,567 | €69,224 | €53,837 | €106,799 | €115,512 | €120,173 | ▲ 4.0% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | €26,279 | €0 | - | - | - | - |
| Other operating charges640/8 | - | - | €2,255 | €25,903 | €3,508 | €5,343 | €4,093 | ▼ 23.4% |
| Non-recurring operating charges66A | - | - | - | - | - | €15,020 | €0 | ▼ 100% |
| Gross operating margin9900 | €21,352 | €138,984 | €240,002 | €244,765 | €178,554 | €195,962 | €199,962 | ▲ 2.0% |
| Operating profit (loss)9901 | €18,260 | €44,617 | €142,244 | €165,025 | €68,246 | €60,086 | €75,696 | ▲ 26.0% |
| Financial income75/76B | - | - | €1 | €1 | €45 | €8 | €20 | ▲ 160% |
| Recurring financial income75 | - | €76 | €1 | €1 | €45 | €8 | €20 | ▲ 160% |
| Financial charges65/66B | - | - | €13,332 | €12,463 | €12,855 | €15,391 | €15,688 | ▲ 1.9% |
| Recurring financial charges65 | €82 | €9,057 | €13,332 | €12,463 | -€11,466 | €15,391 | €15,688 | ▲ 1.9% |
| Non-recurring financial charges66B | - | - | - | - | €24,321 | €0 | - | - |
| Profit (loss) for the period before taxes9903 | €18,178 | €35,637 | €128,913 | €152,562 | €55,436 | €44,703 | €60,028 | ▲ 34.3% |
| Income taxes67/77 | €4,805 | €8,112 | €28,353 | €35,969 | €13,368 | €10,701 | €14,567 | ▲ 36.1% |
| Profit (loss) for the period9904 | €13,372 | €27,525 | €100,561 | €116,593 | €42,068 | €34,002 | €45,460 | ▲ 33.7% |
| Profit (loss) for the period to be appropriated9905 | €13,372 | €27,525 | €100,561 | €116,593 | €42,068 | €34,002 | €45,460 | ▲ 33.7% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total assets20/58 | €0.03m | €1.3m | €1.6m | €2.3m | €2.4m | €2.4m | €2.3m | ▼ 3.8% |
| Fixed assets21/28 | €0.003m | €1.2m | €1.4m | €2.2m | €2.3m | €2.3m | €2.2m | ▼ 2.7% |
| Tangible fixed assets22/27 | €0.003m | €1.2m | €1.4m | €2.2m | €2.3m | €2.3m | €2.2m | ▼ 2.7% |
| Land and buildings22 | - | - | €0.2m | €0.3m | €0.3m | €0.3m | €0.3m | ▼ 2.9% |
| Furniture and vehicles24 | - | - | €0.004m | €0.004m | €0.03m | €0.04m | €0.04m | ▼ 6.8% |
| Other tangible fixed assets26 | - | - | €1.2m | €1.8m | €2.0m | €1.9m | €1.8m | ▼ 2.6% |
| Financial fixed assets28 | - | - | - | €0.001m | €0.001m | €0.001m | €0.001m | = |
| Current assets29/58 | €0.02m | €0.08m | €0.2m | €0.09m | €0.1m | €0.1m | €0.07m | ▼ 29.5% |
| Amounts receivable within one year40/41 | €0.003m | €0.03m | €0.02m | €0.06m | €0.07m | €0.07m | €0.05m | ▼ 30.8% |
| Trade receivables40 | - | - | €0.02m | €0.03m | €0.02m | €0.03m | €0.03m | ▼ 8.9% |
| Other amounts receivable41 | - | - | €60 | €0.03m | €0.05m | €0.04m | €0.02m | ▼ 46.8% |
| Cash at bank and in hand54/58 | €0.02m | €0.06m | €0.2m | €0.009m | €0.007m | €0.02m | €0.02m | ▼ 28.2% |
| Deferred charges and accrued income490/1 | - | - | - | €0.02m | €0.02m | €0.002m | €0.002m | ▲ 3.3% |
| Equity and liabilities | ||||||||
| Total equity and liabilities10/49 | €0.03m | €1.3m | €1.6m | €2.3m | €2.4m | €2.4m | €2.3m | ▼ 3.8% |
| Equity10/15 | €0.02m | €0.05m | €0.1m | €0.3m | €0.3m | €0.3m | €0.4m | ▲ 13.4% |
| Contributions10/11 | €0.006m | - | €0.006m | €0.006m | €0.006m | €0.006m | €0.006m | = |
| Reserves13 | €0.01m | €0.04m | €0.1m | €0.3m | €0.3m | €0.3m | €0.4m | ▲ 13.6% |
| Non-distributable reserves130/1 | - | - | €0.002m | €0.002m | €0 | - | - | - |
| Reserves not available under the articles1311 | - | - | €0.002m | €0.002m | €0 | - | - | - |
| Distributable reserves133 | - | - | €0.1m | €0.3m | €0.3m | €0.3m | €0.4m | ▲ 13.6% |
| Amounts payable17/49 | €0.008m | €1.2m | €1.5m | €2.0m | €2.1m | €2.0m | €1.9m | ▼ 6.7% |
| Amounts payable after more than one year17 | - | €1.1m | €1.2m | €1.1m | €1.0m | €0.9m | €0.9m | ▼ 7.9% |
| Financial debts170/4 | - | - | €1.2m | €1.1m | €1.0m | €0.9m | €0.9m | ▼ 7.9% |
| Amounts payable within one year42/48 | €0.008m | €0.2m | €0.3m | €0.9m | €1.1m | €1.1m | €1.0m | ▼ 5.7% |
| Current portion of amounts payable after more than one year42 | - | - | €0.07m | €0.07m | €0.07m | €0.07m | €0.07m | ▲ 1.0% |
| Financial debts43 | - | - | €0.003m | €0.004m | €0.001m | €0.001m | €0.003m | ▲ 409% |
| Credit institutions430/8 | - | - | €0.003m | €0.004m | €0.001m | €0.001m | €0.003m | ▲ 409% |
| Trade debts44 | €0.007m | €0.003m | €0.09m | €0.2m | €0.04m | €0.09m | €0.05m | ▼ 47.1% |
| Suppliers440/4 | - | - | €0.09m | €0.2m | €0.04m | €0.09m | €0.05m | ▼ 47.1% |
| Taxes, remuneration and social security45 | - | - | €0.04m | €0.1m | €0.05m | €0.02m | €0.02m | ▲ 8.9% |
| Taxes450/3 | - | - | €0.04m | €0.1m | €0.05m | €0.02m | €0.02m | ▲ 8.9% |
| Other amounts payable47/48 | - | - | €0.09m | €0.5m | €0.9m | €0.9m | €0.9m | ▼ 2.7% |
| Accrued charges and deferred income492/3 | - | - | - | €348 | €0 | - | - | - |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €0.01m | €0.03m | €0.1m | €0.1m | €0.04m | €0.03m | €0.05m | ▲ 33.7% |
| + Depreciation and write-downs630 | €0.002m | €0.09m | €0.07m | €0.05m | €0.1m | €0.1m | €0.1m | ▲ 4.0% |
| Operating cash flow (approximation) | €0.02m | €0.1m | €0.2m | €0.2m | €0.1m | €0.1m | €0.2m | ▲ 10.8% |
| Investment in fixed assets (approximation) | - | -€1.3m | -€0.3m | -€0.8m | -€0.3m | -€0.05m | -€0.06m | ▼ 16.9% |
| Change in cash | - | €0.04m | €0.1m | -€0.2m | -€0.001m | €0.02m | -€0.007m | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (7)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 01-06-2026 | 2026-00128640 |
| 31-12-2024 | micro format | 20-06-2025 | 2025-00162995 |
| 31-12-2023 | micro format | 04-07-2024 | 2024-00206171 |
| 31-12-2022 | micro format | 03-07-2023 | 2023-00198876 |
| 31-12-2021 | micro format | 29-07-2022 | 2022-20242747 |
| 31-12-2020 | micro format | 21-06-2021 | 2021-22400502 |
| 31-12-2019 | micro format | 16-06-2020 | 2020-17700494 |
Similar companies · same sector, comparable size
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Vandenberghe Filip |
|
Owners and capital
Capital and shareholders
- 10-10-2023 Converted to available equity
Group and network
Holdings and subsidiaries
1 holdingHoldings 1
-
99%
According to the 2025 annual accounts of Equimaging and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
1 current directorThe board mandates are listed below; here you explore them as a network.
Board mandates elsewhere
1 board mandateHistory
Acts, filings and financial milestones
10-10
Gazette deed
Resignation: Vandenberghe Filip (manager)Appointment: Vandenberghe Filip (director) · Director discharge · Board rule18 facts ▸
- Director resignation, Vandenberghe Filip (manager)
- Director discharge, Vandenberghe Filip
- Board rule, 2, “algemene vergadering” (deed in Dutch)
- Director appointment, Vandenberghe Filip (director (not named in the articles))
- Registered office clause, “9831 Sint-Martens-Latem, Rode Beukendreef 14” (deed in Dutch)
- General meeting, 03-10-2023
- Amendment of the articles (3 times)
- Capital conversion, “beschikbaar voor toekomstige uitkeringen” (deed in Dutch)
- Other provision, “vermindering eigen vermogensrekening niet-opgevraagde inbrengen door vrijstelling volstortingsplicht, vrijstelling van de volstortingsplicht van de niet-opgevra…” (deed in Dutch)
- Purpose change
- Other provision, “aanhouden aandelenregister in elektronische vorm, voorzien in statutaire mogelijkheid” (deed in Dutch)
- Other provision, “uitoefening rechten verbonden aan in pand gegeven aandelen,aandelen waarin meerdere personen gerechtigd zijn,aandelen bezwaard met vruchtgebruik, (her)formuleri…” (deed in Dutch)
- +6 further facts in this act
10-03
Gazette deed
Registered officeRegistered-office move · Power of attorney8 facts ▸
- Board meeting, 18-01-2023
- Registered-office move, Rode Beukendreef 14, 9831 Deurle
- Power of attorney, Moore Finance & Tax BV
- Power of attorney, Tanja De Naeyer
- Power of attorney, Julie De Roy
- Power of attorney, Dominique Jaminet
- Power of attorney, Claudia Beurghs
- Power of attorney, IIse Sterck
About the unread acts
Of the 4 Belgian Official Gazette deeds we know for this company, 2 have been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 44015A0299/00T002 | Flanders | 2,125 m² | 1 · 251 m² | 19.1 m · 2 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Het voeren van een praktijk in diergeneeskunde,het stellen van diagnose,het behandelen van ziekten,letsels en aandoeningen,het toedienen van…” (deed in Dutch)
10 activities (deed in Dutch)
- Het voeren van een praktijk in diergeneeskunde,het stellen van diagnose,het behandelen van ziekten,letsels en aandoeningen,het toedienen van medicatie en het verschaffen van medicatie,het uitvoeren van diergeneeskundige beeldvorming en chirurgie,het verstrekken van intensieve zorgen,gewone medische zorgen,revalidatie en observatie,deze opsomming is geen limitatieve opsomming
- Het uitvoeren van alle prestaties in de klinische biologie
- Het uitvoeren van prestaties als bedrijfsdierenarts en de bijhorende activiteiten
- Het uitvoeren van expertises (zowel gerechtelijke als gewone) binnen het kader van de diergeneeskunde
- Het uitvoeren van diergeneeskundige keuringen
- Het voeren van een praktijk van kunstmatige inseminatie en andere fertiliteitsbehandelingen van dieren,het verlenen van gerelateerde diensten voor zover toegestaan binnen de code van de plichtenleer
- Het verwerven door aankoop,huur,leasing of anderszins van toestellen,apparatuur en accommodaties,inclusief onroerende goederen,om de voorgaande activiteiten te huisvesten,onder meer inzake stalling,opvang,logement en verzorging tijdens hun verblijf in de dierenartspraktijk,voor dieren
- Het ter hand stellen van verzorgingsproducten en verschaffen van geneesmiddelen voor diergeneeskundig gebruik,dierenvoeders en aanverwante benodigdheden
- Het organiseren van,deelnemen aan congressen,scholing,beurzen,evenementen waarin de beoefening,de kennis of de verspreiding van de diergeneeskundige en para-veterinaire activiteiten aan bod komen
- Het uitoefenen van diergeneeskunde volgens wettelijke voorschriften en bepalingen Code der Plichtenleer van de Orde der Dierenartsen
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Equimaging
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Board ruleHow the board is made up, meets and takes decisions.
- “Bestuursorgaan, ARTIKEL 13” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Last Friday of June at 19:00